Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending.
about
Reduced Rate of Repeated Prostate Biopsies Observed in ConfirmMDx Clinical Utility Field Study.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients.
P2860
Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@ast
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@en
type
label
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@ast
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@en
prefLabel
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@ast
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@en
P2093
P2860
P1476
Budget impact model: epigeneti ...... nd reduce healthcare spending.
@en
P2093
Andrew Layton
Arnold Willis
Grant Bagley
Robert Lieberthal
Simon M Willis
Wade Aubry
P2860
P577
2013-01-01T00:00:00Z